We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register to chat with like-minded investors on our interactive forums.
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| Realm Thera. | LSE:RLM | London | Ordinary Share | GB00B3XBCR18 | ORD 10P |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| 0.00 | 0.00% | 11.50 | 10.00 | 13.00 | 0.00 | 01:00:00 |
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| 0 | 0 | N/A | 0 |
TIDMRLM
RNS Number : 1171J
Realm Therapeutics PLC
30 November 2018
TR-1: Standard form for notification of major holdings
Hot Features
Premium
NOTIFICATION OF MAJOR HOLDINGS (to be sent to the relevant issuer and
to the FCA in Microsoft Word format if possible)(i)
1a. Identity of the issuer or the Realm Therapeutics plc
underlying issuer of existing shares
to which voting rights are attached(ii)
:
-----------------------------------------------
1b. Please indicate if the issuer is a non-UK issuer (please mark with
an "X" if appropriate)
Non-UK issuer
----
2. Reason for the notification (please mark the appropriate box or boxes
with an "X")
An acquisition or disposal of voting rights X
----
An acquisition or disposal of financial instruments
----
An event changing the breakdown of voting rights
----
Other (please specify)(iii) :
----
3. Details of person subject to the notification obligation(iv)
Name Peter Kolchinsky (as the managing
member of RA Capital Management LLC)
City and country of registered office
(if applicable) c/o RA Capital Management LLC
20 Park Plaza, Suite 1200
Boston, MA 02116
USA
4. Full name of shareholder(s) (if different from 3.)(v)
Name RA Capital Healthcare Fund, L.P.
as to 5,196,813 ordinary shares (4.46%)
- see further section 11 below.
-----------------------------------------------
City and country of registered office Delaware
(if applicable)
-----------------------------------------------
5. Date on which the threshold was 29 November 2018
crossed or reached(vi) :
-----------------------------------------------
6. Date on which issuer notified (DD/MM/YYYY): 30 November 2018
-----------------------------------------------
7. Total positions of person(s) subject to the notification obligation
% of voting % of voting rights Total of both Total number
rights attached through financial in % (8.A + of voting rights
to shares (total instruments 8.B) of issuer(vii)
of 8. A) (total of 8.B
1 + 8.B 2)
------------------ ---------------------- ---------------- --------------------
Resulting situation
on the date
on which threshold
was crossed
or reached 2.30% 2.30% 116,561,917
------------------ ---------------------- ---------------- --------------------
Position of
previous notification
(if
applicable) 5.52% 5.52%
------------------ ---------------------- ---------------- --------------------
8. Notified details of the resulting situation on the date on which the
threshold was crossed or reached(viii)
A: Voting rights attached to shares
Class/type of Number of voting rights(ix) % of voting rights
shares
ISIN code (if
possible)
Direct Indirect Direct Indirect
(Art 9 of Directive (Art 10 of Directive (Art 9 of Directive (Art 10 of Directive
2004/109/EC) 2004/109/EC) 2004/109/EC) (DTR5.1) 2004/109/EC)
(DTR5.1) (DTR5.2.1) (DTR5.2.1)
-----------------------------
Ordinary Shares 2,681,699 2.30%
------------------------ ----------------------------- ------------------------- ---------------------
SUBTOTAL 8. A 2,681,699 2.30%
------------------------------------------------------- ------------------------------------------------
B 1: Financial Instruments according to Art. 13(1)(a) of Directive 2004/109/EC
(DTR5.3.1.1 (a))
Type of Expiration Exercise/ Number of voting % of voting
financial date(x) Conversion Period(xi) rights that may rights
instrument be acquired if
the instrument
is
exercised/converted.
----------- ----------------------------------- -------------------------------- ---------------------
SUBTOTAL 8. B 1
----------------------------------- -------------------------------- ---------------------
B 2: Financial Instruments with similar economic effect according to
Art. 13(1)(b) of Directive 2004/109/EC (DTR5.3.1.1 (b))
Type of Expiration Exercise/ Physical or Number of % of voting
financial date(x) Conversion cash voting rights rights
instrument Period (xi) settlement(xii)
---------------- ---------------------- ----------------------- --------------------
SUBTOTAL 8.B.2
----------------------- --------------------
9. Information in relation to the person subject to the notification
obligation (please mark the
applicable box with an "X")
Person subject to the notification obligation is not controlled
by any natural person or legal entity and does not control any other
undertaking(s) holding directly or indirectly an interest in the
(underlying) issuer(xiii)
Full chain of controlled undertakings through which the voting rights X
and/or the
financial instruments are effectively held starting with the ultimate
controlling natural person or legal entity(xiv) (please add additional
rows as necessary)
Name(xv) % of voting rights % of voting rights Total of both if
if it equals or through financial it equals or is
is higher than the instruments if it higher than the
notifiable threshold equals or is higher notifiable threshold
than the notifiable
threshold
---------------------- --------------------- ------------------------
Peter Kolchinsky N/A N/A N/A
(as the managing
member of RA Capital
Management LLC)
---------------------- --------------------- ------------------------
RA Capital Management
LLC 2.30% 2.30%
---------------------- --------------------- ------------------------
10. In case of proxy voting, please identify:
Name of the proxy holder
-----------------------------------------------
The number and % of voting rights
held
-----------------------------------------------
The date until which the voting rights
will be held
-----------------------------------------------
11. Additional information(xvi)
Peter Kolchinsky is the managing member of RA Capital Management, LLC.
RA Capital Management, LLC is the general partner of RA Capital Healthcare
Fund, L.P. and also the investment manager with regard to further shares
in the issuer where the registered holder of those shares falls below
the lowest notifiable threshold. All percentage calculations are based
on the current issued share capital of Realm Therapeutics plc of 116,561,917
ordinary shares.
Place of completion Boston, USA
Date of completion 30 November 2018
-----------------
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
END
HOLEAKFEDEDPFFF
(END) Dow Jones Newswires
November 30, 2018 11:08 ET (16:08 GMT)
1 Year Realm Thera. Chart |
1 Month Realm Thera. Chart |
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
